Pharmaceutical executive with over 25 years experience. Currently Market Access Executive Director for AstraZeneca responsible for Strategic Pricing, Trade and Contract Operations as well as Government Pricing and Operations. She is an innovative and results-oriented Strategic Executive with extensive history developing and implementing efficient, cost-effective and innovative business strategies strengthening company operations. Proven track record of designing and executing innovative solutions that promote strategy development and process improvement across commercial, regulatory and financial business segments. Actively engaged with Federal and State Representatives informing and shaping policy.